Terpene and cannabinoid analytics in the lab
Cannabinoids (THC, CBD, CBG, CBN etc.) are usually measured via HPLC (high-performance liquid chromatography), since this method detects heat-sensitive acid forms (THCA, CBDA) unchanged. Terpenes, by contrast, are usually analysed via GC or GC-MS (gas chromatography), since they're volatile and suited to the gas phase. A full 'potency profile' often shows 10+ cannabinoids and 20-40 terpenes, forming the chemical basis for the discussed 'entourage effect'.
TL;DR
- HPLC measures cannabinoids at room temperature without decomposing the acid forms.
- GC/GC-MS is the standard for volatile terpenes.
- A full profile often shows 10+ cannabinoids and 20-40 terpenes.
- Terpene profiles are used for strain identification and quality assessment.
Why HPLC for cannabinoids?
Gas chromatography would heat the sample and decarboxylate THCA/CBDA into their neutral forms — skewing the result for fresh or raw products. HPLC separates molecules at room temperature in a liquid mobile phase through a column and detects them via UV (usually at 220 and 280 nm), allowing both acid and neutral cannabinoid forms to be quantified unchanged.
What terpene profiles reveal
Terpenes are volatile hydrocarbons that shape a strain's smell and taste — myrcene (earthy, musky), limonene (citrus), caryophyllene (peppery) and linalool (floral) are among the most common. GC-MS separates these molecules in the gas phase and identifies them via their mass spectrum. A detailed terpene profile enables strain comparisons independent of THC content and feeds discussions around the 'entourage effect' (Russo 2021), though its clinical relevance is not yet conclusively established scientifically.
Swiss regulatory framework and the 1 percent limit in analytics
In Switzerland, the precise analysis of cannabinoids is the legal dividing line between legal products and illegal narcotics. The legislator defines the limit at a total THC content of less than one percent. This value is calculated from free tetrahydrocannabinol and tetrahydrocannabinolic acid, taking into account the molar mass difference using the formula total THC equals THC plus THCA multiplied by the factor zero point eight seven seven. Laboratories must perform this calculation exactly, as exceeding this limit legally classifies the product immediately as an illegal narcotic under the Narcotics Act, which entails criminal consequences.
For official control and legal trade, the validation of these values by accredited laboratories is essential. Authorities such as the Federal Office of Public Health (BAG) and the Federal Food Safety and Veterinary Office (BLV) rely on these analyses for inspections. Seamless quality control is also mandatory within the framework of the Swiss cannabis pilot trials. Consumers and producers alike depend on the measurement methods being sensitive enough to reproducibly determine these limits, especially since a strict zero-tolerance policy applies to road traffic with a detection limit of 1.5 micrograms of THC per litre of blood.
- Exact calculation of the total THC content to comply with the legal one percent limit.
- Distinction between legal CBD products and illegal cannabis under the Narcotics Act.
- Importance of analytics for quality control in government-approved pilot trials.
- Safeguarding consumers with regard to the strict limits in Swiss road traffic.
Sampling and extraction as a key process
The reliability of a certificate of analysis begins long before the actual measurement in the chromatograph, starting with representative sampling. Since cannabinoids and terpenes are unevenly distributed on a single plant or within a batch, selective sampling of individual flowers leads to distorted results. Professional laboratories therefore require standardised protocols in which samples are taken from different parts of the batch and then completely homogenised. Only through careful grinding and mixing of the material can it be ensured that the tiny amount analysed in the laboratory reflects the actual average of the entire batch.
Homogenisation is followed by the extraction of the analytes from the plant matrix using suitable solvents such as methanol or ethanol. This step requires precisely controlled conditions regarding temperature, time and ultrasonic treatment to guarantee complete dissolution of the cannabinoids and terpenes without thermal degradation. Incomplete extractions lead to systematically low measurement results, while overly aggressive treatment can prematurely decarboxylate the sensitive acidic cannabinoids. The choice of the correct solvent and the subsequent filtration are therefore crucial for the purity of the injected sample.
- Representative sampling across the entire batch prevents selective measurement errors.
- Homogenisation of the plant material ensures the comparability of the measurement results.
- Gentle extraction processes prevent the unwanted degradation of cannabinoid acids.
- Use of certified solvents to avoid contamination in the measurement system.
Typical sources of error and deviations in the laboratory
Despite state-of-the-art equipment, significant measurement deviations can occur in cannabinoid and terpene analysis, which are often attributable to human or systemic errors. One of the most common sources of error is the insufficient calibration of the measuring instruments or the use of expired reference standards. Since the detectors must be regularly calibrated to known concentrations, minimal deviations in the standard solutions lead to a distortion of the entire series of measurements. In addition, contamination in the separation columns of the HPLC or GC systems can lead to signal overlaps that falsely increase or mask individual cannabinoids.
Another critical factor is the instability of the samples during storage and preparation. Cannabinoids and especially terpenes are extremely sensitive to light, air and heat. If the samples are not stored in a cool and dark place before analysis, THC, for example, quickly oxidises to cannabinol (CBN), which artificially lowers the measured active ingredient content and causes the CBN value to rise. The evaporation of volatile terpenes at room temperature also quickly leads to incomplete profiles. Laboratories must therefore adhere to strict guidelines for sample management to maintain the integrity of the samples from goods receipt to measurement.
- Calibration errors due to inaccurate reference standards falsify the quantitative results.
- Column contamination in the chromatograph causes peak overlaps and misinterpretations.
- Unintentional oxidation of THC to CBN due to improper sample storage under light exposure.
- Loss of volatile terpenes due to insufficient cooling prior to gas chromatographic analysis.
Quality standards and the importance of ISO accreditation
To guarantee the comparability and legal validity of analytical results, the accreditation of testing laboratories according to international standards is of central importance. The ISO/IEC 17025 standard specifies the general requirements for the competence of testing and calibration laboratories. A laboratory accredited according to this standard must continuously demonstrate that its measurement methods are validated, its equipment is regularly maintained, and its personnel are qualified. For producers and distributors in Switzerland, this provides the assurance that, in case of doubt, certificates of analysis will be recognized as reliable evidence by authorities and courts.
An essential component of quality assurance is regular proficiency testing, in which several laboratories analyze identical samples and compare the results. These interlaboratory comparisons reveal systematic deviations between different institutes and promote the harmonization of analytical methods. In Switzerland, compliance with these standards is strictly monitored, as faulty analyses can, in the worst-case scenario, lead to marketable products being falsely confiscated or health-threatening batches entering the market. Choosing an accredited laboratory is therefore an essential step in risk minimization.
- ISO/IEC 17025 accreditation ensures the international recognition and validity of the data.
- Regular participation in proficiency testing minimizes systematic deviations between laboratories.
- Validated testing methods protect producers from unjustified regulatory measures.
- Transparent documentation of all analytical steps ensures the traceability of measurement results.
FAQ
Why do COA values differ between labs?
Different calibration standards, extraction methods and instrument types cause variation of a few percentage points — ISO/IEC 17025 accreditation reduces this variance.
Why do some products show only 'total THC' without individual values?
That's often a cost-saving or marketing simplification — a complete COA should report THCA and Δ9-THC separately.
Are terpene tests standard in Switzerland?
No, they're usually optional and mostly offered by higher-end suppliers to differentiate their products.
What's the difference between HPLC-UV and LC-MS for cannabinoids?
LC-MS is more sensitive and specific (ideal for trace analysis of rare cannabinoids), HPLC-UV is cheaper and usually sufficient for major cannabinoids.
How is total THC calculated in Swiss laboratories?
Total THC is calculated mathematically using the formula total THC equals THC plus THCA multiplied by the factor zero point eight seven seven. This calculation is necessary because the acidic form, THCA, is converted into active THC by decarboxylation when heated. Since the acidic form has a higher molecular weight, the factor corrects for the loss of mass during this process. Swiss laboratories must apply this formula to reliably verify compliance with the legal limit of less than one percent total THC for marketable CBD products.
Why is the HPLC method indispensable for measuring cannabinoid acids?
The HPLC method is indispensable because it enables the separation and measurement of cannabinoids at room temperature without destroying heat-sensitive acid forms such as THCA and CBDA. In contrast to gas chromatography, where samples are heated intensely and thus inevitably decarboxylate, the chemical structure remains intact during HPLC. This is the only way to determine the exact ratio between acidic and neutral cannabinoids in the raw plant, which is crucial for quality control and compliance with regulatory requirements in Switzerland.
What role does analytical testing play in the Swiss cannabis pilot trials?
In the Swiss pilot trials, analytical testing ensures the legally mandated quality control and standardisation of the distributed products. Every batch distributed at the points of sale must be analysed in detail beforehand for its cannabinoid content to guarantee a consistent dosage for the participants. In addition, laboratory analysis serves to rule out contaminants such as pesticides, heavy metals, or microbiological impurities. This ensures the scientific validity of the studies and protects the health of consumers in accordance with the requirements of the Federal Office of Public Health (FOPH).
How does faulty sampling affect the analytical result?
Faulty sampling leads to unrepresentative results that either overestimate or underestimate the actual active ingredient content of a batch. Since cannabinoids are unevenly distributed on the plant — upper flowers usually show higher concentrations than parts of the plant close to the ground —, selective sampling distorts the overall picture. If the sample is not completely homogenised before analysis, the laboratory only measures a random section. For reliable quality control, a standardised sampling protocol across the entire batch is therefore mandatory.